- 30 March 2013, Straits Times Advertisement
- 6 January 2013, Straits Times Postgraduate Studies Special
- 6 December 2012, Education Singapore Special, The Star, Malaysia's No 1 English Daily
- 7 July 2012, Straits Times Advertisement
- 24 March 2012, Straits Times Advertisement
- 8 January 2012, Straits Times Advertisement, Postgraduate Studies Supplement
- 12 November 2011, Straits Times Advertisement
- 2 July 2011, Straits Times Advertisement
- March 2011, Straits Times Advertisement
- 12 February 2011, Straits Times Advertisement
- 8 January 2011, Straits Times Advertisement - Advance Your Career in the Healthcare & Pharmaceutical Industries
- 5 August 10, Clinical Research – An opportunity for primary care physicians
- 16 June 10, New Paper Adult Go Guide – Three Way Partnership for better pharmaceutical skills
- 16 April 10, Strait Times advertisement – Symposium on Building a Research-Based Healthcare service in Singapore
- March 2010, Pharmaceutical Society of Singapore eBulletin Issue no. 57 - http://www.pss.org.sg/ebulletin/Issue57/Event_NUS.pdf
- 6 February 10, Strait Times advertisement - Advance Your Career in the Healthcare & Pharmaceutical Industries
- 10 July 09, Straits Times Advertisement - Postgraduate Professional Development & Continuing Education Programmes for the Pharmaceutical & Healthcare Industry
- 30 March 09, IDEAS - Centre for Instructional Technology's Newsletter
Video conferencing enables Temple University-NUS SAGE Certification Programme Lectures
- 28 March 09, Strait Times advertisement - Advance Your Career in the Healthcare & Pharmaceutical Industries
- 13 December 08, Straits Times advertisement
Find out more about NUSAGE from EDB
Manufacturing New Medicines
Singapore has made significant inroads in biologics manufacturing, with Baxter, Lonza, GlaxoSmithKline and Roche announcing their investments to set up major biologics facilities that amount to US$2 billion in capital expenditure. This builds on the city state's strong track record in both small-molecule active pharmaceutical ingredient and secondary manufacturing.
Today, 8 of the world's top pharmaceutical and biotechnology companies have invested in more than 25 commercial-scale manufacturing facilities in Singapore. They include Abbott, GlaxoSmithKline, Lonza, Merck Sharp & Dohme, Novartis, Pfizer, Roche and sanofi-aventis. These facilities are validated by regulatory authorities from the US and Europe, and produce innovative medicines for the global market.
Singapore offers excellent intellectual property protection, sophisticated infrastructure and a skilled manpower base to drive process development and support the commercial-scale production of the industry's most innovative products.
In addition, the city-state offers a stable political and civic environment to ensure long-term returns for global manufacturers' capital-intensive investments. The government has set aside a 360-hectare stretch of ready-prepared and specifically-zoned land, called Tuas Biomedical Park (TBP), for pharmaceutical and biologics manufacturing. Equipped with established infrastructure such as roads, drainage systems, power, water supply, and telecommunication lines, TBP presents a plug-and-play environment that enables leading biomedical sciences companies to set up manufacturing facilities here with minimal lead time. These companies can also leverage on third-party utilities and services such as steam, natural gas, chilled water and waste treatment. TBP is currently home to leading pharmaceutical, biotechnology and medical technology companies such as Abbott, Alcon, CIBA Vision, GlaxoSmithKline Biologicals, Lonza, Merck Sharp & Dohme, Novartis, Pfizer and Roche. These companies have collectively invested over S$6 billion to set up manufacturing facilities in TBP.
The government is committed to working with the industry to upgrade employees’ skills, train new workers and promote best practices. The recent launch of the National University of Singapore Academy of GxP Excellence (NUSAGE) is a case in point. NUSAGE, a collaboration between the Singapore government, the National University of Singapore, and industry partners, is one of the first industry-wide training initiatives in the region and complements company specific training centres in Singapore.
Regional Centre to Promote Best Practices
Reliable skilled manpower